SCHEMBL7933157

SCHEMBL7933157

CNC(=O)CCc1cc(NC(=O)c2ccc(Br)o2)ccc1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.52
ALDH1A1 P00352 6/20 0.52
HPGD P15428 3/20 0.52
HTT P42858 2/20 0.52
THRB P10828 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
RAB9A P51151 10/20 0.51
SMN1; SMN2 Q16637 10/20 0.51
TSHR P16473 3/20 0.51
MAPK10 P53779 2/20 0.51
NPC1 O15118 8/20 0.50
PKM P14618 2/20 0.50
GRM4 Q14833 1/20 0.50
POLB P06746 2/20 0.49
LMNA P02545 5/20 0.48
HSD17B10 Q99714 2/20 0.48
TP53 P04637 3/20 0.48
L3MBTL1 Q9Y468 3/20 0.48
NFKB1 P19838 2/20 0.48
NFKB2 Q00653 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7941769 0.88 POLB (0.54) MAPTALDH1A1HPGDHTTTDP1
SCHEMBL7942651 0.77 BACE1 (0.47) RAB9ASMN1; SMN2NPC1
SCHEMBL7942303 0.76 NPC1 (0.53) MAPTALDH1A1HTTRAB9ASMN1; SMN2
SCHEMBL7942306 0.76 MEN1 (0.51) MAPTRAB9ASMN1; SMN2NPC1PKM
SCHEMBL24670540 0.74 MAPT (0.66) MAPTALDH1A1HPGDHTTTHRB
SCHEMBL29803858 0.74 MAPT (0.66) MAPTALDH1A1HPGDHTTTHRB
SCHEMBL7942653 0.73 BACE1 (0.46) RAB9ASMN1; SMN2NPC1GRM4
SCHEMBL7940427 0.73 SMN1; SMN2 (0.48) MAPTALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL16015428 0.73 PLK1 (0.40) RAB9A
SCHEMBL20109473 0.72 MTNR1A (0.39) RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010047372-A1 2-AMINOPYRIDIN-4-ONE AND 2-AMINOPYRIDINE DERIVATIVE BOTH HAVING BACE1-INHIBITING ACTIVITY 塩野義製薬株式会社 (JP) 2010-04-29 WO disclosed